Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10340)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2015 (publication date) through Dec 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
|
Wang FC, Pei JX, Zhu J, Zhou NJ, Liu DS, Xiong HF, Liu XQ, Lin DJ, Xie Y. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: |
Wang FC, Pei JX, Zhu J, Zhou NJ, Liu DS, Xiong HF, Liu XQ, Lin DJ, Xie Y. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i25/7764.htm |
| Number | Citing Articles |
| 1 |
Noelle C. Rubas, Rafael Peres, Braden P. Kunihiro, Nina P. Allan, Krit Phankitnirundorn, Riley K. Wells, Trevor McCracken, Rosa H. Lee, Lesley Umeda, Andie Conching, Ruben Juarez, Alika K. Maunakea. HMGB1 mediates microbiome-immune axis dysregulation underlying reduced neutralization capacity in obesity-related post-acute sequelae of SARS-CoV-2. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-023-50027-1
|
| 2 |
Fahad Khan, Meenakshi Verma, Indra Rautela, Vijay Jagdish Upadhye, Pratibha Pandey, Rahul Kumar. Correlation of Neuroinflammation and Therapeutic Targets in Perioperative Neurocognitive Disorders. Current Pharmaceutical Biotechnology 2025; 26(14): 2310 doi: 10.2174/0113892010315764240920064245
|
| 3 |
Lidan Luo, Shuai Wang, Bohao Chen, Mei Zhong, Ruili Du, ChunShan Wei, Furong Huang, Xinhui Kou, Yufeng Xing, Guangdong Tong. Inhibition of inflammatory liver injury by the HMGB1-A box through HMGB1/TLR-4/NF-κB signaling in an acute liver failure mouse model. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.990087
|
| 4 |
Dechao Tan, Hisa Hui Ling Tseng, Zhangfeng Zhong, Shengpeng Wang, Chi Teng Vong, Yitao Wang. Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications. International Journal of Molecular Sciences 2022; 23(19): 10988 doi: 10.3390/ijms231910988
|
| 5 |
Yong Wang, Hui Weng, Jian Fei Song, Yun Hua Deng, Shuang Li, Hong Bo Liu. Activation of the HMGB1-TLR4-NF-κB pathway may occur in patients with atopic eczema. Molecular Medicine Reports 2017; 16(3): 2714 doi: 10.3892/mmr.2017.6942
|
| 6 |
Hongliang Huang, Yuexiang Dai, Yingying Duan, Zhongwen Yuan, Yanxuan Li, Maomao Zhang, Wenting Zhu, Hang Yu, Wenfei Zhong, Senling Feng. Effective prediction of potential ferroptosis critical genes in clinical colorectal cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1033044
|
| 7 |
Jiandong Li, Peng Yin, Ping Gong, An Lv, Zhicong Zhang, Fenghua Liu. 8‐Methoxypsoralen protects bovine mammary epithelial cells against lipopolysaccharide‐induced inflammatory injury via suppressing JAK/STAT and NF‐κB pathway. Microbiology and Immunology 2019; 63(10): 427 doi: 10.1111/1348-0421.12730
|
| 8 |
Han Wu, Zheng Chen, Jun Xie, Li-Na Kang, Lian Wang, Biao Xu. High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications. Mediators of Inflammation 2016; 2016: 1 doi: 10.1155/2016/3896147
|
| 9 |
Yi Liu, Guo-Bin Zhuang, Xue-Zhi Zhou. HMBG1 as a Driver of Inflammatory and Immune Processes in the Pathogenesis of Ocular Diseases. Journal of Ophthalmology 2018; 2018: 1 doi: 10.1155/2018/5195290
|
| 10 |
Vikram Thakur, Jayanarayanan Sadanandan, Munmun Chattopadhyay. High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy. International Journal of Molecular Sciences 2020; 21(3): 881 doi: 10.3390/ijms21030881
|
| 11 |
Yi Yang, Chenyang Han, Li Guo, Qiaobin Guan. High expression of the HMGB1–TLR4 axis and its downstream signaling factors in patients with Parkinson's disease and the relationship of pathological staging. Brain and Behavior 2018; 8(4) doi: 10.1002/brb3.948
|
| 12 |
Miao Liu, Junli Zhao. Circular RNAs in Diabetic Nephropathy: Updates and Perspectives. Aging and disease 2022; 13(5): 1365 doi: 10.14336/AD.2022.0203
|
| 13 |
Yue Shi, Yixuan Ma, Rong Wang, Xiaoer Liu, Wenqing Duan, Dejian Huang, Xiaoting Wang, Jinming Zhao, Rubin Tan. HMGB1: a multifaceted mediator of cell death pathways in cardiovascular diseases. Apoptosis 2025; 30(11-12): 2612 doi: 10.1007/s10495-025-02144-7
|
| 14 |
Federico Biscetti, Andrea Flex, Stefano Alivernini, Barbara Tolusso, Elisa Gremese, Gianfranco Ferraccioli. The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/5230374
|
| 15 |
Yahui Fu, Jinlai Lei, Yan Zhuang, Kun Zhang, Daigang Lu. Overexpression of HMGB1 A-box reduced IL-1β-induced MMP expression and the production of inflammatory mediators in human chondrocytes. Experimental Cell Research 2016; 349(1): 184 doi: 10.1016/j.yexcr.2016.10.014
|
| 16 |
Mohamed A. Lebda, Ingi H. Elmassry, Nabil M. Taha, Mohamed S. Elfeky. Nanocurcumin alleviates inflammation and oxidative stress in LPS-induced mastitis via activation of Nrf2 and suppressing TLR4-mediated NF-κB and HMGB1 signaling pathways in rats. Environmental Science and Pollution Research 2022; 29(6): 8294 doi: 10.1007/s11356-021-16309-9
|
| 17 |
Qingling Guo, Haili Qu, Hong Zhang, Xia Zhong. Prunella vulgaris L. Attenuates Experimental Autoimmune Thyroiditis by Inhibiting HMGB1/TLR9 Signaling. Drug Design, Development and Therapy 2021; : 4559 doi: 10.2147/DDDT.S325814
|
| 18 |
Yang Deng, Bo Liu, Changqi Fu, Long Gao, Yuan Shen, Kun Liu, Qianru Li, Jinshan Cao, Wei Mao. Lipopolysaccharide stimulates bovine endometrium explants through toll‑like receptor 4 signaling and PGE2 synthesis. Prostaglandins, Leukotrienes and Essential Fatty Acids 2021; 168: 102272 doi: 10.1016/j.plefa.2021.102272
|
| 19 |
Paramita Basu, Camelia Maier, Dayna L. Averitt, Arpita Basu. NLR family pyrin domain containing 3 (NLRP3) inflammasomes and peripheral neuropathic pain - Emphasis on microRNAs (miRNAs) as important regulators. European Journal of Pharmacology 2023; 955: 175901 doi: 10.1016/j.ejphar.2023.175901
|
| 20 |
Laura Ciarlo, Francesca Marzoli, Paola Minosi, Paola Matarrese, Stefano Pieretti. Ammonium Glycyrrhizinate Prevents Apoptosis and Mitochondrial Dysfunction Induced by High Glucose in SH-SY5Y Cell Line and Counteracts Neuropathic Pain in Streptozotocin-Induced Diabetic Mice. Biomedicines 2021; 9(6): 608 doi: 10.3390/biomedicines9060608
|
| 21 |
Jianmin Zhou, Ou Shuang, Jian Li, Zijun Cai, Chong Wu, Wenyu Wang. miR‑34a alleviates spinal cord injury via TLR4 signaling by inhibiting HMGB‑1. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.7102
|
| 22 |
Runxiao Lv, Lili Du, Xueyong Liu, Fenghua Zhou, Zhiqiang Zhang, Lixin Zhang. Rosmarinic acid attenuates inflammatory responses through inhibiting HMGB1/TLR4/NF-κB signaling pathway in a mouse model of Parkinson's disease. Life Sciences 2019; 223: 158 doi: 10.1016/j.lfs.2019.03.030
|
| 23 |
Xu Lin, Haiting Huang, Yanwu You, Chunrong Tang, Xiangjun Gu, Meiying Huang, Junhua Tan, Jie Wang. Activation of TLR5 induces podocyte apoptosis. Cell Biochemistry and Function 2016; 34(2): 63 doi: 10.1002/cbf.3165
|
| 24 |
YUJIE HU, CHONG HU, JIERONG YIN, JIALING ZHONG, YUAN DENG, GUOSHUAI YANG. MiR-181c-5p ameliorates learning and memory in sleep-deprived mice via HMGB1/TLR4/NF-κB pathway. Anais da Academia Brasileira de Ciências 2023; 95( suppl 1) doi: 10.1590/0001-3765202320220750
|
| 25 |
Hui-hui Zhou, Ye-ming Zhang, Sheng-peng Zhang, Qi-xiang Xu, Ya-qing Tian, Ping Li, Di Cao, Yong-qiu Zheng. Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.724410
|
| 26 |
Maria del Carmen Ponce de León-Rodríguez, Jean-Pierre Guyot, Caroline Laurent-Babot. Intestinalin vitrocell culture models and their potential to study the effect of food components on intestinal inflammation. Critical Reviews in Food Science and Nutrition 2019; 59(22): 3648 doi: 10.1080/10408398.2018.1506734
|
| 27 |
Gui-Qing Liu, Xian-Hong Zuo, Li-Na Jiang, Yu-Ping Zhang, Li-Min Zhang, Zi-Gang Zhao, Chun-Yu Niu. Inhibitory effect of post-hemorrhagic shock mesenteric lymph drainage on the HMGB1 and RAGE in mouse kidney. Renal Failure 2016; 38(1): 131 doi: 10.3109/0886022X.2015.1105026
|
| 28 |
Sandamali A. Ekanayaka, Sharon A. McClellan, Xudong Peng, Ronald P. Barrett, Rebecca Francis, Linda D. Hazlett. HMGB1 Antagonist, Box A, Reduces TLR4, RAGE, and Inflammatory Cytokines in the Cornea ofP. aeruginosa-Infected Mice. Journal of Ocular Pharmacology and Therapeutics 2018; 34(10): 659 doi: 10.1089/jop.2018.0073
|
| 29 |
Liping Chen, Junhua Li, Zhenghao Ye, Binghua Sun, Lu Wang, Yu Chen, Jian Han, Meiping Yu, Ying Wang, Qi Zhou, Ursula Seidler, De’an Tian, Fang Xiao. Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.585094
|
| 30 |
Deepti Sharma, Anju Singh, Shrikant Kukreti, Mallika Pathak, Lajpreet Kaur, Vinod Kaushik, Himanshu Ojha. Protection by ethyl pyruvate against gamma radiation induced damage in bovine serum albumin. International Journal of Biological Macromolecules 2020; 150: 1053 doi: 10.1016/j.ijbiomac.2019.10.110
|
| 31 |
Na Dong, Xinyao Xu, Chenyu Xue, Chensi Wang, Xinran Li, Chongpeng Bi, Anshan Shan. Ethyl pyruvate inhibits LPS induced IPEC-J2 inflammation and apoptosis through p38 and ERK1/2 pathways. Cell Cycle 2019; 18(20): 2614 doi: 10.1080/15384101.2019.1653106
|
| 32 |
Min Li, Junwen Hu, Yucong Peng, Jingbo Li, Reng Ren. CircPTK2-miR-181c-5p-HMGB1: a new regulatory pathway for microglia activation and hippocampal neuronal apoptosis induced by sepsis. Molecular Medicine 2021; 27(1) doi: 10.1186/s10020-021-00305-3
|
| 33 |
Wen Zeng, Xu Zhang, Yulu Jiang, Yuxiang Luo, Zuao Wang, Xiaohong Du, Leifeng Chen. Dualistic Roles of High Mobility Group Box 1 in Cancer and Inflammation. Cancer Medicine 2025; 14(23) doi: 10.1002/cam4.71455
|
| 34 |
Ri-Na Wu, Tian-Yu Yu, Ji-Chao Zhou, Meng Li, Hui-Kuan Gao, Can Zhao, Rui-Qing Dong, Dian Peng, Zhuo-Wei Hu, Xiao-Wei Zhang, Yong-Quan Wu. Targeting HMGB1 ameliorates cardiac fibrosis through restoring TLR2-mediated autophagy suppression in myocardial fibroblasts. International Journal of Cardiology 2018; 267: 156 doi: 10.1016/j.ijcard.2018.04.103
|
| 35 |
Liyan Yue, Jinhui Dong, Jianxing Wang, Xiaoyan Yin, Xiumin Ren, Ou Xu, Chunguang Shan. High mobility group box 1 inhibition by BoxA attenuates ovalbumin-induced allergic rhinitis in mice. Autoimmunity 2022; 55(2): 118 doi: 10.1080/08916934.2021.2021512
|
| 36 |
Hideki Mori, Masamoto Murakami, Teruko Tsuda, Kenji Kameda, Ryo Utsunomiya, Kana Masuda, Ken Shiraishi, Xiuju Dai, Mikiko Tohyama, Hiroki Nakaoka, Koji Sayama. Reduced-HMGB1 suppresses poly(I:C)-induced inflammation in keratinocytes. Journal of Dermatological Science 2018; 90(2): 154 doi: 10.1016/j.jdermsci.2018.01.007
|
| 37 |
Tian Zhang, Xu-Wen Guan, John G. Gribben, Feng-Ting Liu, Li Jia. Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma. Cell Death & Disease 2019; 10(5) doi: 10.1038/s41419-019-1563-8
|
| 38 |
Yuhan Yang, Ling Yang, Sheng Jiang, Ting Yang, Jingbin Lan, Yun Lei, Hao Tan, Kejian Pan. HMGB1 mediates lipopolysaccharide-induced inflammation via interacting with GPX4 in colon cancer cells. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01289-6
|